L Reneman
Overview
Explore the profile of L Reneman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Schrantee A, Reneman L
Neuropharmacology
. 2013 Jul;
84:159-69.
PMID: 23851258
Dopamine abnormalities underlie a wide variety of psychopathologies, including ADHD and schizophrenia. A new imaging technique, pharmacological magnetic resonance imaging (phMRI), is a promising non-invasive technique to visualize the dopaminergic...
12.
Klomp A, van Wingen G, de Ruiter M, Caan M, Denys D, Reneman L
Neuroimage
. 2013 Mar;
75:108-116.
PMID: 23501048
Non-invasive assessment of human neurotransmitter function is a highly valuable tool in clinical research. Despite the current interest in task-based pharmacological MRI (phMRI) for the assessment of neural correlates of...
13.
Schouw M, Caan M, Geurts H, Schmand B, Booij J, Nederveen A, et al.
Eur Neuropsychopharmacol
. 2013 Feb;
23(11):1491-502.
PMID: 23415394
Preclinical studies suggest that dexamphetamine (dAMPH) can lead to monoaminergic neurotoxicity. This exploratory study aimed to investigate effects of recreational dAMPH use on the dopamine (DA) and noradrenaline (NA) systems...
14.
Schouw M, Kaag A, Caan M, Heijtel D, Majoie C, Nederveen A, et al.
Neuroimage
. 2013 Jan;
72:1-9.
PMID: 23296186
Pharmacological magnetic resonance imaging (phMRI) maps the neurovascular response to a pharmacological challenge and is increasingly used to assess neurotransmitter systems. Here we investigated the hemodynamic response to a dopaminergic...
15.
Schouw M, de Ruiter M, Kaag A, van den Brink W, Lindauer R, Reneman L
Drug Alcohol Depend
. 2012 Nov;
130(1-3):52-60.
PMID: 23142493
Background: Dopamine (DA) is involved in systems governing motor actions, motivational processes and cognitive functions. Preclinical studies have shown that even relatively low doses of d-amphetamine (dAMPH) (equivalent to doses...
16.
Klomp A, Caan M, Denys D, Nederveen A, Reneman L
Neuroimage
. 2012 Jul;
63(3):1695-700.
PMID: 22842212
Assessment of cerebral serotonin (5-HT) function with arterial spin labeling (ASL)-based pharmacological magnetic resonance imaging (phMRI) could be a highly useful tool in clinical psychiatric research. The goal of this...
17.
Reneman L, de Win M, Booij J, van den Brink W, den Heeten G, Freling N, et al.
AJNR Am J Neuroradiol
. 2012 Jun;
33(10):1971-4.
PMID: 22723061
We determined the prevalence and clinical relevance of incidental brain and head and neck findings in young healthy volunteers with MR imaging. We retrospectively analyzed the MR images obtained from...
18.
Schouw M, Gevers S, Caan M, Majoie C, Booij J, Nederveen A, et al.
Eur Neuropsychopharmacol
. 2012 Jan;
22(8):537-45.
PMID: 22209360
3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is a popular recreational drug that has been shown to induce loss of brain serotonin (5-HT) neurons. The purpose of this study was to determine the...
19.
Klomp A, Tremoleda J, Wylezinska M, Nederveen A, Feenstra M, Gsell W, et al.
Neuroimage
. 2011 Aug;
59(1):218-26.
PMID: 21840402
Rationale: With the growing prevalence of psychotropic drug prescriptions among children and adolescents, the need for studies on lasting effects of drug exposure on the developing brain rises. Fluoxetine is...
20.
Reneman L
J Neural Transm Suppl
. 2003 Oct;
(66):61-83.
PMID: 14582803
Of the designer drugs, the amphetamine analogues are the most popular and extensively studied, ecstasy (3,4-methylenedioxymethamphetamine; MDMA) in particular. They are used recreationally with increasing popularity despite animal studies showing...